What they found (summary): Amylin is a critical partner of insulin in metabolism, the loss of amylin in T2DM is as significant as the loss of insulin The AMY1 receptor in the area postrema is the primary target for the appetite effect Amyloid aggregation is the main problem with native amylin, proline substitutions (the Pramlintide strategy) are essential The half-life of native amylin is only 13 minutes, that is why lipidated analogs like Cagrilintide are necessary Perspective: amylin + GLP-1 combinations are the natural evolution of metabolic pharmacotherapy Why it matters: This is the reference article for amylin pharmacology
The immediate availability of nutrients helps to restore balance, boost energy levels, and support various bodily functions, leading to noticeable improvements in well-being and appearance
References Anisimov, V., Khavinson, V., Provinciali, M., Alimova, I., Baturin, D., Popovich, I., & Franceschi, C
Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S
Improved Skin & Bone Health : Increases collagen synthesis for firmer, youthful skin and supports stronger bone density
Dec 2016;17(1):60
